| 1/3 | US=16 / Urologia Keller ET. Biology and imaging: biology and therapeutic basis of prostate cancer bone metastasis. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 175-91. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; BASE TERAPEUTICA DE METASTASES OSSEAS; CANCER DE PROSTATA; ENDOTELINA-1; ET-1; IL-6; OPG; OSTEOPROTEGERINA; HORMONIO DA PARATIREOIDE; PTHRP; RANKL; RECEPTOR DO FATOR NUCLEAR-K B |
| 2/3 | US=16 / Ortopedia Body JJ. Systemic treatments: overview of osteoclast inhibitors. In: Jasmin C, Coleman RE, Coia LR, Capanna R, Saillan G. Textbook of bone metastases. New Jersey: John Wiley & Sons, 2005. p. 291-9. ISBN 978-0-471-87742-5. OSTEOCLASTOS; METASTASE NEOPLASICA; NEOPLASIAS OSSEAS; MIELOMA MULTIPLO; OSTEOPROTEGERINA; CALCITONINA |
| 3/3 | US=881 / Tese/FAP Silva EFP. Avaliação clínica, morfológica e molecular do carcinoma epidermoide oral com envolvimento mandibular. [Clinical, morphological and molecular evaluation of oral squamous cell carcinoma with mandibular invasion]. São Paulo, 2021. 69 p. Tese(Doutorado)-Fundação Antônio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2021/EFPSilva/EFPSilva.pdf CARCINOMA DE CELULAS ESCAMOSAS; RECEPTOR ATIVADOR DE FATOR NUCLEAR KAPPA-B; OSTEOPROTEGERINA; INTERLEUCINA-6; PROGNOSTICO; MANDIBULA |